242 results on '"SPADARO, Giuseppe"'
Search Results
2. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
3. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
4. High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study
5. Gender dimorphism in IgA subclasses in T2-high asthma
6. Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function
7. Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
8. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
9. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)
10. Size-based effects of anthropogenic ultrafine particles on activation of human lung macrophages
11. Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma
12. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
13. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
14. Severe asthma: One disease and multiple definitions
15. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
16. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis
17. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
18. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
19. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
20. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.
21. Immunoglobulins G modulate endothelial function and affect insulin sensitivity in humans
22. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
23. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality
24. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)
25. Psychological processes in the experience of hereditary angioedema in adult patients: an observational study
26. Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency
27. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies
28. The Severe Asthma Network in Italy: Findings and Perspectives
29. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
30. Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.
31. Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study
32. Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group
33. Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach
34. Water diffusion and swelling stresses in ionizing radiation cured epoxy matrices
35. Delay in diagnosis affects the clinical outcome in a cohort of cvid patients with marked reduction of iga serum levels
36. Rapid infusions of human normal immunoglobulin 50 g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia
37. Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients
38. Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS)
39. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
40. Water diffusion and swelling stresses in highly crosslinked epoxy matrices
41. Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review.
42. Exhaled Nitric Oxide as Biomarker of Type 2 Diseases.
43. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.
44. Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID).
45. Is there a role for microbiome-based approach in common variable immunodeficiency?
46. In-situ polymerization of polyaniline in radiation functionalized polypropylene films
47. Absorption kinetics and swelling stresses in hydrothermally aged epoxies investigated by photoelastic image analysis
48. Chronic Diarrhea in Common Variable Immunodeficiency: a Case Series and Review of the Literature
49. Effect of hydrothermal ageing on the thermal and delamination fracture behaviour of CFRP composites
50. Hydrogel films engineered in a mesoscopically ordered structure and responsive to ethanol vapors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.